Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Interferon Maintenance in Advanced Multiple Myeloma After Using High-Dose Melphalan as Myeloablative Chemotherapy: A Pilot Study

NCT00003007 is registered in ClinicalTrials.gov with University of Tennessee as lead sponsor.

NCT NCT00003007
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00003007 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Interferon Maintenance in Advanced Multiple Myeloma After Using High-Dose Melphalan as Myeloablative Chemotherapy: A Pilot Study
Lead sponsor
University of Tennessee
Phase
Phase 2
Overall status
Completed
Start date
July 31, 1996
Completion date
January 31, 2004
Enrollment
Not reported
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

multiple myeloma and plasma cell neoplasm